Document Detail


Oral L-arginine supplementation in acute myocardial infarction therapy: a meta-analysis of randomized controlled trials.
MedLine Citation:
PMID:  19938054     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The objective was to analyze completed trials assessing the effect of oral L-arginine supplementation on clinical outcomes of patients with acute myocardial infarction (AMI). BACKGROUND: Prior trials suggest that oral L-arginine administration improves endothelial function in patients with stable coronary artery disease (CAD). However, it is still unclear whether oral supplementation of L-arginine has any effect on clinical outcomes in patients with unstable CAD, such as AMI. METHODS: We systematically searched PubMed, Cochrane Library, Embase, reviews, and reference lists of relevant articles. The search strategy paired the term "arginine" with the following: "coronary heart disease," "myocardial infarction," "cardiovascular disease," "ischemia," and "trial." We conducted a meta-analysis of randomized, placebo-controlled L-arginine supplementation trials that evaluated clinical outcomes in AMI patients. Two reviewers independently assessed the trials. Differences were resolved by consensus. RESULTS: Only 2 trials (927 participants) were included. None of the 2 studies showed a significant difference in event rate between the L-arginine and placebo groups. In an overall pooled estimate, there was a 7% reduction in mortality in the L-arginine treatment group (105/459, 22.9%) compared with the control group (111/455, 24.4%), which did not reach statistical significance (risk ratio [RR]: 0.93, 95% confidence interval [CI]: 0.74-1.17; P = 0.54). CONCLUSION: Oral L-arginine supplementation has no effect on the clinical outcomes of patients with AMI.
Authors:
Tao Sun; Wen-Bai Zhou; Xin-Ping Luo; Yao-Liang Tang; Hai-Ming Shi
Related Documents :
9352964 - Effect of platelet glycoprotein iib/iiia receptor inhibition on distal embolization dur...
8774964 - Limitations of electrocardiography in the diagnosis of acute myocardial infarction--com...
8960574 - Chronobiology of acute myocardial infarction: cardiac arrhythmia suppression trial (cas...
2565684 - One-year prognosis of primary ventricular fibrillation complicating acute myocardial in...
16799254 - Intracoronary injection of granulocyte colony-stimulating factor ameliorates the progre...
17483584 - Medial medullary infarct aggravates central poststroke pain caused by previous lateral ...
Publication Detail:
Type:  Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical cardiology     Volume:  32     ISSN:  1932-8737     ISO Abbreviation:  Clin Cardiol     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-11-30     Completed Date:  2010-02-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7903272     Medline TA:  Clin Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  649-52     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, P.R. China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Arginine / administration & dosage*
Cardiovascular Agents / administration & dosage*
Double-Blind Method
Humans
Middle Aged
Myocardial Infarction / drug therapy*,  mortality
Prospective Studies
Randomized Controlled Trials as Topic
Treatment Outcome
Chemical
Reg. No./Substance:
0/Cardiovascular Agents; 74-79-3/Arginine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A comparison of auditory brainstem responses and behavioral estimates of hearing sensitivity in Lemu...
Next Document:  Do Media Players Cause Interference with Pacemakers?